US proposes expanding outbound investment controls on China to biotechnology

Washington has proposed expanding US controls on outbound investment in China to biotechnology, potentially subjecting some joint drug-development ventures, offshore spinoffs and equity investments to national security review.

Detected & updated continuously · Source: Nebula